• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿酸与白蛋白比值与经皮冠状动脉介入治疗(PCI)后无复流现象的关联:一项系统评价和荟萃分析

Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.

作者信息

Ozbay Mustafa B, Degirmen Serhat, Gullu Aysenur, Nriagu Bede N, Omer Mohammed, Özen Yasin, Yayla Cagri

机构信息

Internal Medicine, Penn Medicine Princeton Medical Center, Plainsboro, USA.

Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.

出版信息

Cureus. 2025 Apr 4;17(4):e81712. doi: 10.7759/cureus.81712. eCollection 2025 Apr.

DOI:10.7759/cureus.81712
PMID:40322371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12050074/
Abstract

The no-reflow phenomenon (NR) following percutaneous coronary intervention (PCI) is an unpredictable complication linked to increased in-hospital mortality and adverse cardiovascular outcomes. Reliable predictors of NR remain unclear. This systematic review and meta-analysis aimed to evaluate the association between serum uric acid to albumin ratio (UAR) and NR development after PCI. A comprehensive search of MEDLINE, Cochrane, and EMBASE databases identified observational studies assessing this relationship. Studies that provided multivariate regression analyses to determine whether UAR is an independent predictor of NR were included, and pooled odds ratios (OR) were calculated using random effects models. Three studies with a total of 2,199 patients were included. The pooled analysis demonstrated a significant association between higher UAR and an increased risk of NR (OR: 3.04; 95% CI: 2.26-4.10; p < 0.00001; I² = 0%). These findings indicate that a higher serum UAR is independently associated with NR development and may serve as a useful, easily measurable predictor in clinical practice.

摘要

经皮冠状动脉介入治疗(PCI)后出现的无复流现象(NR)是一种不可预测的并发症,与住院死亡率增加和不良心血管结局相关。NR的可靠预测因素仍不明确。本系统评价和荟萃分析旨在评估血清尿酸与白蛋白比值(UAR)与PCI后NR发生之间的关联。对MEDLINE、Cochrane和EMBASE数据库进行全面检索,确定了评估这种关系的观察性研究。纳入提供多变量回归分析以确定UAR是否为NR独立预测因素的研究,并使用随机效应模型计算合并比值比(OR)。共纳入3项研究,总计2199例患者。汇总分析表明,较高的UAR与NR风险增加之间存在显著关联(OR:3.04;95%CI:2.26-4.10;p<0.00001;I²=0%)。这些发现表明,较高的血清UAR与NR发生独立相关,在临床实践中可能是一个有用的、易于测量的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/e8589a8ef6d2/cureus-0017-00000081712-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/a8ff87786c8d/cureus-0017-00000081712-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/c15a59da8776/cureus-0017-00000081712-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/e8589a8ef6d2/cureus-0017-00000081712-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/a8ff87786c8d/cureus-0017-00000081712-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/c15a59da8776/cureus-0017-00000081712-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/12050074/e8589a8ef6d2/cureus-0017-00000081712-i03.jpg

相似文献

1
Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.血清尿酸与白蛋白比值与经皮冠状动脉介入治疗(PCI)后无复流现象的关联:一项系统评价和荟萃分析
Cureus. 2025 Apr 4;17(4):e81712. doi: 10.7759/cureus.81712. eCollection 2025 Apr.
2
The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction.血清尿酸/白蛋白比值与ST段抬高型心肌梗死患者无复流的相关性
Angiology. 2023 Apr;74(4):381-386. doi: 10.1177/00033197221110700. Epub 2022 Jun 21.
3
The Association Between No-Reflow and Serum Uric Acid/Albumin Ratio in Patients With Acute Myocardial Infarction Without ST Elevation.血尿酸/白蛋白比值与急性非 ST 段抬高型心肌梗死无复流现象的相关性研究。
Angiology. 2024 Jan;75(1):72-78. doi: 10.1177/00033197221139685. Epub 2022 Dec 1.
4
Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.尿酸与白蛋白比值作为慢性冠状动脉综合征伴非阻塞性冠状动脉疾病患者冠状动脉慢血流现象的新型预测因子。
BMC Cardiovasc Disord. 2024 Jul 13;24(1):358. doi: 10.1186/s12872-024-04040-5.
5
The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention.尿酸/白蛋白比值:经皮冠状动脉介入治疗后不稳定型心绞痛患者长期心脏死亡率的新预测指标。
Scand J Clin Lab Invest. 2022 Jul;82(4):304-310. doi: 10.1080/00365513.2022.2084698. Epub 2022 Jun 8.
6
[Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].[ST段抬高型心肌梗死患者行直接冠状动脉介入治疗时血清尿酸水平与冠状动脉血流的相关性]
Zhonghua Yi Xue Za Zhi. 2012 Nov 27;92(44):3100-3.
7
Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.尿酸与白蛋白比值与冠心病经药物洗脱支架置入术后支架内再狭窄的关系。
Coron Artery Dis. 2023 Dec 1;34(8):589-594. doi: 10.1097/MCA.0000000000001300. Epub 2023 Oct 11.
8
R wave peak time and no reflow following primary percutaneous coronary intervention: Immediate and short-term outcomes.R 波峰时间和直接经皮冠状动脉介入治疗后无再灌注:即刻和短期结果。
J Electrocardiol. 2023 Jul-Aug;79:66-74. doi: 10.1016/j.jelectrocard.2023.03.003. Epub 2023 Mar 12.
9
Prediction of the no-reflow phenomenon during percutaneous coronary intervention using coronary computed tomography angiography.使用冠状动脉计算机断层扫描血管造影术预测经皮冠状动脉介入治疗期间的无复流现象。
Heart Vessels. 2011 Jul;26(4):363-9. doi: 10.1007/s00380-010-0059-3. Epub 2010 Nov 6.
10
The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.实验室参数对直接经皮冠状动脉介入治疗后 ST 段抬高型心肌梗死患者无复流现象的预测价值:一项荟萃分析。
Clin Cardiol. 2024 Feb;47(2):e24238. doi: 10.1002/clc.24238.

本文引用的文献

1
Newly defined biomarker for the no reflow phenomenon in patients with non-ST elevation acute coronary syndrome; uric acid to creatinine ratio.非ST段抬高型急性冠状动脉综合征患者无复流现象的新定义生物标志物;尿酸与肌酐比值。
Acta Cardiol. 2025 Feb;80(1):61-69. doi: 10.1080/00015385.2025.2452101. Epub 2025 Jan 16.
2
The uric acid/albumin ratio might be a better indicator for predicting repeat revascularization in young patients with acute coronary syndrome: Beyond inflammatory biomarkers.尿酸/白蛋白比值可能是预测急性冠脉综合征年轻患者重复血运重建的更好指标:超越炎症生物标志物。
PLoS One. 2024 Aug 26;19(8):e0306178. doi: 10.1371/journal.pone.0306178. eCollection 2024.
3
Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.
尿酸与白蛋白比值作为慢性冠状动脉综合征伴非阻塞性冠状动脉疾病患者冠状动脉慢血流现象的新型预测因子。
BMC Cardiovasc Disord. 2024 Jul 13;24(1):358. doi: 10.1186/s12872-024-04040-5.
4
The Association Between No-Reflow and Serum Uric Acid/Albumin Ratio in Patients With Acute Myocardial Infarction Without ST Elevation.血尿酸/白蛋白比值与急性非 ST 段抬高型心肌梗死无复流现象的相关性研究。
Angiology. 2024 Jan;75(1):72-78. doi: 10.1177/00033197221139685. Epub 2022 Dec 1.
5
Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死患者全身炎症指标与无复流现象的关系
Angiology. 2023 Apr;74(4):387-394. doi: 10.1177/00033197221115562. Epub 2022 Jul 20.
6
The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction.血清尿酸/白蛋白比值与ST段抬高型心肌梗死患者无复流的相关性
Angiology. 2023 Apr;74(4):381-386. doi: 10.1177/00033197221110700. Epub 2022 Jun 21.
7
CRP Albumin Ratio May Predict No Reflow in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Stenosis.C 反应蛋白白蛋白比值可能预测行经皮冠状动脉介入治疗的隐静脉桥狭窄患者无复流。
Angiology. 2023 Jan;74(1):55-61. doi: 10.1177/00033197221098277. Epub 2022 May 2.
8
"No-Reflow" Phenomenon: A Contemporary Review.“无复流”现象:当代综述
J Clin Med. 2022 Apr 16;11(8):2233. doi: 10.3390/jcm11082233.
9
Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.血尿酸白蛋白比值可预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者对比剂肾病。
Angiology. 2023 Jan;74(1):70-78. doi: 10.1177/00033197221091605. Epub 2022 Apr 22.
10
Uric Acid-to-Albumin Ratio: A Novel Marker for the Extent of Coronary Artery Disease in Patients with Non-ST-Elevated Myocardial Infarction.尿酸与白蛋白比值:非ST段抬高型心肌梗死患者冠状动脉疾病程度的新型标志物
Pulse (Basel). 2021 Jun;8(3-4):99-107. doi: 10.1159/000514533. Epub 2021 Mar 4.